2016年美国病理学家学会甲状腺细针穿刺细胞学实践调查趋势
美国病理学家学会2016年对2013家实验室调查甲状腺细针穿刺细胞学实践,878家(43.6%)回复。结果显示多数穿刺由放射科医生在超声引导下完成,89.8%实验室使用Bethesda报告系统,分子检测多基于临床需求而非穿刺诊断,反思性检测罕见。
要点
- 多数实验室由放射科医生行甲状腺细针穿刺,超声引导占92.1%。
- 89.8%实验室采用Bethesda系统报告甲状腺细胞学。
- 分子检测多按临床需求进行,反思性检测较少。
核心结论
- 2016年美国甲状腺细针穿刺细胞学实践标准化术语常用,病理医生承担多数即刻 adequacy 评估,分子检测多按需申请。
研究设计与样本
- 2016年向参与CAP非妇科细胞学教育项目的2013家实验室发放调查,收集2015-2016年甲状腺细针穿刺相关数据,878家(43.6%)回复。
主要发现
- 放射科医生在多数实验室执行甲状腺细针穿刺(70%,529/756),其次为内分泌科医生(18.7%,141/756),92.1%(699/759)在超声引导下进行。
- 32.6%(251/769)的回复者对非病理提供者的不满意率提供反馈;术中 adequacy 评估主要由病理主治医生(77.4%,490/633)或细胞技术员(28.4%,180/633)完成。
- 89.8%(701/781)实验室使用Bethesda甲状腺细胞病理报告系统;68.1%(184/270)基于临床医生请求进行分子检测而非穿刺诊断。
- 甲状腺切除与先前细胞学结果的相关性多回顾性进行(38.4%,283/737),用于病理医生判读质量保证。
关键数值与推荐
- 放射科医生执行穿刺占70%(529/756),内分泌科医生占18.7%(141/756)。
- 超声引导穿刺占92.1%(699/759)。
- Bethesda系统使用率89.8%(701/781)。
- 基于临床请求的分子检测占68.1%(184/270)。
- 回顾性细胞-组织相关性分析占38.4%(283/737)。
临床怎么用
- 甲状腺细针穿刺多由放射科医生在超声引导下完成,病理科应关注非病理提供者的不满意率反馈。
- 病理医生或细胞技术员可承担术中 adequacy 评估,并采用Bethesda系统标准化报告。
- 分子检测宜按临床需求申请,反思性检测不常规开展;细胞-组织相关性分析可用于病理医生质量保证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: The College of American Pathologists periodically surveys laboratories to determine changes in cytopathology practices. We report the results of a 2016 survey concerning thyroid fine-needle aspiration (FNA). OBJECTIVE.—: To provide a cross-sectional survey of thyroid cytology practices in 2016. DESIGN.—: In 2016, a survey was sent to 2013 laboratories participating in the College of American Pathologists Non-Gynecologic Cytology Education Program (NGC-A) requesting data from 2015-2016 on several topics relating to thyroid FNA. RESULTS.—: A total of 878 laboratories (43.6% of 2013) replied to the survey. Radiologists performed the most thyroid FNA procedures in most laboratories (70%; 529 of 756), followed by endocrinologists (18.7%; 141 of 756), and most of these were performed under ultrasound guidance (92.1%; 699 of 759). A total of 32.6% of respondents (251 of 769) provided feedback on unsatisfactory rates for nonpathology providers who performed FNA. Intraprocedural adequacy assessment was primarily performed by attending pathologists (77.4%; 490 of 633) or cytotechnologists (28.4%; 180 of 633). Most laboratories used the Bethesda System for Reporting Thyroid Cytopathology (89.8%; 701 of 781) and performed molecular testing based on clinician request (68.1%; 184 of 270) rather than FNA diagnosis. Correlation of thyroid excisions with prior cytology results most often occurred retrospectively (38.4%; 283 of 737) and was used for pathologist interpretive quality assurance purposes. CONCLUSIONS.—: These survey results offer a snapshot of national thyroid FNA cytology practices in 2016 and indicate that standardized cytology terminology is commonly used; pathologists perform most immediate adequacy assessments for thyroid FNA; laboratories use correlation statistics to evaluate pathologists' performance; and molecular tests are increasingly requested for indeterminate interpretations, but reflex molecular testing is rare.
引用
- Mais DD, Crothers BA, Davey DD, et al. Trends in Thyroid Fine-Needle Aspiration Cytology Practices: Results From a College of American Pathologists 2016 Practice Survey. Arch Pathol Lab Med. 2019. PMID: 31100017. doi:10.5858/arpa.2018-0429-CP
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。